The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
about
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationHigh TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patientsA novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinomaTGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment.Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resectionPrognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsEnhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysisImmunotherapy for hepatocellular carcinoma patients: is it ready for prime time?Intestinal flora imbalance promotes alcohol-induced liver fibrosis by the TGFβ/smad signaling pathway in mice.Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE.Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.
P2860
Q26772329-F274F389-B913-4E92-B72A-E905DF7ED562Q33798379-F2C7D919-3AA3-44BF-9624-B2E1B7AAD96FQ35933166-015119D1-B3E8-472A-8679-0CE09DD29BA9Q37327988-E4C792D6-A40B-47A5-AC5F-AAE582EC1D42Q37536946-4D6A1E25-B338-49EF-8321-2B1EA0F7C787Q37687816-14AC3E24-99DF-42DF-93BB-88828C8BEF46Q37706180-E4AC4AF9-C028-41E9-A47E-319552E07C41Q37706763-AAE32205-5701-4A2C-B1AE-E27DB8B310BBQ39195314-E94C67E1-C81E-480E-906C-7516E707EC23Q45070547-6147E58B-0265-45FB-B384-F00552C8551CQ47132438-2D864006-2A3C-487C-8E28-CF1414F0A537Q47339205-362DCBC6-7391-4590-9794-8E0F4A7749AEQ49169300-87C309B8-6714-488F-B3F9-43282EA7FF72Q52565829-64740E2B-E26F-4850-900A-2E3D96ABBAFB
P2860
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@ast
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@en
type
label
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@ast
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@en
prefLabel
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@ast
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
@en
P2093
Bao-Gang Peng
Li-Jian Liang
Long-Juan Zhang
Qing-Hua Cao
Shao-Qiang Li
Shun-Jun Fu
Shun-Li Shen
Yun-Peng Hua
P2860
P2888
P356
10.1186/S12885-015-1127-Y
P407
P577
2015-03-11T00:00:00Z
P5875
P6179
1044069256